Skip to main content

David Aronoff Archives

Aronoff departing VUMC to become chair of the Department of Medicine at Indiana University School of Medicine

Aug. 11, 2021—David Aronoff, MD, Addison B. Scoville Jr. Professor of Medicine and director of the Division of Infectious Diseases, is departing Vanderbilt University Medical Center to become chair of the Department of Medicine at Indiana University School of Medicine.

Read more


American Airlines boosts travelers’ peace of mind with VUMC expertise

Jun. 26, 2020—American Airlines has created a new Travel Health Advisory Panel that includes Vanderbilt University Medical Center infectious disease experts to advise on health and cleaning matters as travelers return over the summer.

Read more


Target trials support drug safety in pregnant patients

May. 27, 2020—Out of concern for fetal safety, pregnant people have typically been excluded from drug trials. And when human health is on the line, drug studies assessing fetal safety in animal models may be viewed as far from definitive.

Read more


Ibuprofen and COVID-19: a doctor’s guidance

Mar. 18, 2020—Last week, France’s health ministry urged people who have been infected by the novel severe acute respiratory syndrome coronavirus (SARS-CoV-2) to avoid taking over-the- counter nonsteroidal anti-inflammatory drugs (NSAIDs) such as ibuprofen, naproxen and aspirin because they might increase the severity of the infection.

Read more


Treating C. diff: new purpose for an old drug?

Sep. 24, 2019—An inexpensive generic drug once used to prevent gastrointestinal ulcers in people taking daily NSAIDs protects against C. diff infection in mice.

Read more


Major grant renews AIDS education, training initiative

Jul. 24, 2019—VUMC has been awarded a five-year, nearly $23 million federal grant to continue coordinating AIDS education and training efforts in Tennessee and seven other southeastern states.

Read more


Vanderbilt team shows how stomach bug can trigger cancer

Jul. 11, 2019—Researchers at Vanderbilt University and the University of Michigan in Ann Arbor have obtained the first high-resolution image of a molecular “machine” used by the insidious stomach bug Helicobacter pylori (H. pylori) to inject a cancer-causing protein into the stomach lining.

Read more


Pain relievers a risk for C. diff?

Jan. 17, 2019—A link between anti-inflammatory drugs such as ibuprofen and C. diff infection suggests caution against overusing such drugs in patients at high risk for infection.

Read more


Fetal membranes and microbial threats

Oct. 26, 2018—Understanding how cells communicate in the membranes surrounding the developing fetus could suggest new strategies for preventing infections, premature birth and adverse pregnancy outcomes.

Read more


VUMC drug repurposing initiative gaining momentum

Apr. 19, 2018—Drug repurposing involves establishing an additional approved indication for a drug already at market.

Read more


Grant bolsters study of potential new therapy for C. diff infection

Mar. 22, 2018—According to the Centers for Disease Control and Prevention, in 2011 in the United States there were almost half a million Clostridium difficile infections, and one in 11 patients 65 or older with a healthcare-associated C. diff infection died within 30 days of diagnosis.

Read more


Aronoff elected to microbiology academy

Apr. 27, 2017—Infectious diseases specialist David Aronoff, M.D., recently became one of 73 new fellows of the American Academy of Microbiology, an honorific leadership group within the American Society of Microbiology.

Read more


Recent Stories from VUMC News and Communications Publications

Vanderbilt Medicine
Hope
Momentum
VUMC Voice

more